Role of zoledronic acid in the prevention and treatment of osteoporosis
Agnès Räkel, Andrée Boucher, Louis-Georges Ste-MarieEndocrinology, Department of Medicine. Centre de recherche du CHUM, Université de Montréal, Montréal, QC, CanadaAbstract: Taken once a year, intravenous zoledronic acid (Zol) (Reclast&...
Enregistré dans:
Auteurs principaux: | Räkel A, Boucher A, Ste-Marie L-G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ab0974cfecea4416af1a7e6ac9610e07 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Management of osteoporosis in the aging male: Focus on zoledronic acid
par: Paul K Piper Jr, et autres
Publié: (2009) -
Once-yearly zoledronic acid in hip fracture prevention
par: Oddom Demontiero, et autres
Publié: (2009) -
The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
par: Wang Z, et autres
Publié: (2021) -
Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
par: Shi C, et autres
Publié: (2018) -
A review of minodronic acid hydrate for the treatment of osteoporosis
par: Tanishima S, et autres
Publié: (2013)